Can I read Ischemia-Modified Albumin in ACS Patients on EtoBox?

Ischemia-Modified Albumin in ACS Patients by dr fatima is a document available to read on EtoBox.

What is Ischemia-Modified Albumin in ACS Patients about?

This study investigates ischemia-modified albumin (IMA) as a potential biomarker for acute coronary syndrome, focusing on its correlation with obesity, blood pressure, and lipid profiles in a sample of 200 patients. Results indicate that elevated IMA levels correlate strongly with increased low-density lipoproteins, triglycerides, cholesterol, and blood pressure, suggesting its utility in predicting cardiovascular risk. The findings support the use of IMA in clinical settings for early detection of ischemic

Author

dr fatima

Language

EN